Mountain Valley MD Holdings Past Earnings Performance
Past criteria checks 0/6
Mountain Valley MD Holdings has been growing earnings at an average annual rate of 28.8%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 18% per year.
Key information
28.8%
Earnings growth rate
41.0%
EPS growth rate
Pharmaceuticals Industry Growth | 23.1% |
Revenue growth rate | 18.0% |
Return on equity | -82.9% |
Net Margin | -8,700.0% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How Mountain Valley MD Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 0 | -8 | 3 | 0 |
31 Mar 24 | 0 | -8 | 3 | 0 |
31 Dec 23 | 0 | -7 | 3 | 1 |
30 Sep 23 | 0 | -4 | 3 | 1 |
30 Jun 23 | 0 | -6 | 3 | 1 |
31 Mar 23 | 0 | -7 | 4 | 1 |
31 Dec 22 | 0 | -7 | 4 | 2 |
30 Sep 22 | 0 | -9 | 6 | 2 |
30 Jun 22 | 0 | -9 | 7 | 2 |
31 Mar 22 | 0 | -10 | 7 | 2 |
31 Dec 21 | 0 | -14 | 8 | 3 |
30 Sep 21 | 0 | -12 | 6 | 2 |
30 Jun 21 | 0 | -10 | 4 | 2 |
31 Mar 21 | 0 | -8 | 3 | 1 |
31 Dec 20 | 0 | -20 | 3 | 0 |
30 Sep 20 | 0 | -19 | 3 | 0 |
30 Jun 20 | 0 | -19 | 3 | 0 |
31 Mar 20 | 0 | -19 | 3 | 0 |
Quality Earnings: MVMD is currently unprofitable.
Growing Profit Margin: MVMD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MVMD is unprofitable, but has reduced losses over the past 5 years at a rate of 28.8% per year.
Accelerating Growth: Unable to compare MVMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MVMD is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).
Return on Equity
High ROE: MVMD has a negative Return on Equity (-82.88%), as it is currently unprofitable.